17 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
6 Dec 22
Regulation FD Disclosure
8:01am
, Dr. Barone held the academic position of Reader in Translational Rheumatology and Academic Director of Business Engagement for the College of Medical … encoded Exposure at the Site of Action Insufficient CAR-T ingress factors turn cold tumors hot Expose TAAs* via oncolysis Target binding / engagement
DEF 14A
3clgqoga9dx22u8fm
2 Sep 22
Definitive proxy
8:30am
10-K
EX-10.12
wlqn4io
29 Mar 22
Annual report
8:46am
10-K
EX-10.13
ayrsz2a utpf5f4
29 Mar 22
Annual report
8:46am
10-K
9pd43def
29 Mar 22
Annual report
8:46am
S-1/A
EX-10.5.5
ioxubp8otrhy cs
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.6
jsdhqgifyhormuon
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.4
ox9tz0l9 v4zv0csst
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.6
xf3vra3f4lq3
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.1
kgm9wie
16 Jul 21
IPO registration (amended)
6:07am
- Prev
- 1
- Next